HeartWare Drops Valtech Deal Under Shareholder Pressure; Stays Focused On VADs
This article was originally published in The Gray Sheet
Executive Summary
The ventricular-assist device company HeartWare International announced it was terminating its September 2015 agreement to buy heart-valve repair firm Valtech on the same day it disclosed an agreement with an activist shareholder group that opposed the deal.